AI assistant
PEAK PROCESSING LIMITED — Investor Presentation 2020
Sep 9, 2020
65568_rns_2020-09-09_de41257f-48c5-46f5-9995-250758277dbb.pdf
Investor Presentation
Open in viewerOpens in your device viewer
==> picture [595 x 148] intentionally omitted <==
ASX Announcement | September 10 2020 Althea Group Holdings (ASX:AGH)
Investor Webinar - CBD products to become available over the counter under proposed TGA reclassification
10 September 2020: Australian pharmaceutical company Althea Group Holdings Limited (ASX:AGH) (‘Althea’ or ‘the Company’) is pleased to invite shareholders and investors to a briefing with CEO Joshua Fegan to discuss the interim decision to down schedule cannabidiol (CBD) released yesterday.
Details of the event are as follows:
Event: Althea Group Holdings Investor Briefing Presenters: CEO, Joshua Fegan Time: Friday 11[th] September 2020, 10.30am (AEST) Where: Zoom Webinar, details to be provided upon registration
To register your interest for the webinar, please click through to the link below: https://us02web.zoom.us/webinar/register/WN_R12m0xdvRWSk_XbyHEWDKw
Participants will be able to submit questions via the chat function throughout the webinar, however, to ensure all questions can be answered in the allotted time we encourage shareholders to send through questions via email beforehand to the Company via Investor Relations partner Jane Morgan at [email protected]
Discussion points:
-
The interim decision by the Therapeutic Goods Administration (TGA) to amend the current Poisons Standard to down schedule cannabidiol (CBD) to allow greater access through a new Schedule 3 entry[1]
-
The result of the proposed amendment which would allow Australian patients to purchase CBD products upon consultation with a pharmacist, without the need for a prescription
-ENDS-
Authorised by: Robert Meissner, Company Secretary
For further information, please contact:
Althea Media Enquiries Josh Fegan Dan Francome CEO & Managing Director Media Relations M: 1300 70 20 20 P: +613 9650 5096 E: [email protected] E: [email protected]
==> picture [595 x 92] intentionally omitted <==
==> picture [595 x 148] intentionally omitted <==
Althea Group Holdings Limited (ASX:AGH)
Althea Group Holdings Ltd (ASX:AGH) is a global pharmaceutical company and supplier of medicinal cannabis. Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.
Althea currently operates within highly regulated medicinal cannabis markets including Australia, United Kingdom and Germany, with plans to expand into emerging markets throughout Asia and Europe.
To learn more, please visit: www.althea.life
==> picture [595 x 92] intentionally omitted <==